908 Devices (MASS) Capital Expenditures Growth (3y) (2023 - 2026)
908 Devices (MASS) Capital Expenditures Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.33 Bn | 174.04 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 128.11 Bn | 125.23 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 107.76 Bn | 98.54 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 67.95 Bn | 66.50 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 1.81% |
| 6 | GE HealthCare Technologies | 28.43 Bn | 26.14 Bn | 1.98 Bn | 7.57% |
| 7 | Dexcom | 28.31 Bn | 27.20 Bn | 750.30 Mn | 0.84% |
| 8 | Smith & Nephew | 26.77 Bn | 26.19 Bn | - | - |
| 9 | Koninklijke Philips | 25.33 Bn | 22.21 Bn | 2.07 Bn | 2.15% |
| 10 | 908 Devices | 265.65 Mn | 153.90 Mn | 6.88 Mn | 97.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 97.59% |
| Dec 31, 2025 | 23.19% |
| Sep 30, 2025 | -26.22% |
| Jun 30, 2025 | -269.46% |
| Mar 31, 2025 | 74.99% |
| Dec 31, 2024 | 122.65% |
| Sep 30, 2024 | 20.31% |
| Jun 30, 2024 | -36.69% |
| Mar 31, 2024 | 364.67% |
| Dec 31, 2023 | -99.37% |
| Sep 30, 2023 | 34.02% |
| Jun 30, 2023 | 265.37% |
| Mar 31, 2023 | -27.59% |